phenylalanine has been researched along with lovastatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bok, SH; Choi, MS; Jeong, TS; Lee, MK; Lee, S; Park, EJ; Park, YB | 1 |
| Kang, W; Kim, Y; Park, K | 1 |
2 other study(ies) available for phenylalanine and lovastatin
| Article | Year |
|---|---|
Effect of 3,4-di(OH)-cinnamate synthetic derivative on plasma and hepatic cholesterol level and antioxidant enzyme activities in high cholesterol-fed rats.
Topics: Animals; Caffeic Acids; Cholesterol; Cholesterol, Dietary; Coumaric Acids; Glutathione Peroxidase; Glutathione Reductase; Hydroxymethylglutaryl CoA Reductases; Liver; Lovastatin; Male; Microsomes, Liver; Phenylalanine; Rats; Rats, Sprague-Dawley; Sterol O-Acyltransferase; Superoxide Dismutase | 2004 |
Effect of fluvastatin, lovastatin, nifedipine and verapamil on the systemic exposure of nateglinide in rabbits.
Topics: Animals; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Calcium Channel Blockers; Cyclohexanes; Cytochrome P-450 CYP2C9; Cytochrome P450 Family 2; Diabetes Mellitus, Type 2; Drug Interactions; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Indoles; Lovastatin; Male; Nateglinide; Nifedipine; Phenylalanine; Rabbits; Steroid 21-Hydroxylase; Verapamil | 2010 |